Santam Ltd Overview
Santam is South Africa's largest general (short-term) insurer. It holds roughly 23% of industry revenue (KPMG survey, 2024 data) and leads the independent-broker channel in both personal and commercial lines. Founded in 1918, and the original parent of Sanlam, it has been majority-owned by Sanlam since 1954 and listed on the JSE since about 1964. The group combines several businesses: an intermediated core (Broker Solutions and Client Solutions); a direct insurer (MiWay); embedded and partnership distribution (MTN device cover and the MultiChoice/DStv insurance book); a specialist commercial and agricultural franchise; a treaty reinsurer (Santam Re); and a cell-captive and structured-insurance arm (Centriq and Santam Structured Insurance). Its FutureFit 2030 strategy targets international diversification through Santam Syndicate 1918 at Lloyd's (underwriting from January 2026) and a reinsurance office in India's GIFT City (opened April 2026). The listing is expected to end in early 2027 if Sanlam's R505-per-share take-private is approved.
What the company does
Santam underwrites non-life risks in four areas:
-
Motor, property and liability risks of South African individuals and businesses.
-
Specialist risks for corporates and agriculture: engineering, marine and transportation, aviation, crop, heavy haulage, travel and casualty.
-
Treaty and facultative reinsurance for insurers in Africa, the Middle East, Asia and, since 2026, the Lloyd's market.
-
Insurance structures where Santam's licence carries a client's own risk, through cell captives and structured insurance. Santam earns fees, an investment margin and selected underwriting participation on these.
Company's own description (paraphrased). In its FY2025 and H1 2026 reports, Santam describes itself as South Africa's largest general insurer. It is an authorised financial services provider and licensed non-life insurer, and the controlling company of its group. It frames its purpose around being "FutureFit": defending leadership in intermediated distribution, scaling direct and partnership channels, and diversifying internationally (AFS FY2025 Directors' report; IFS H1 2026).
Independent characterisation. Santam is a mature, scale-advantaged property and casualty franchise in a concentrated and slow-growing domestic market. Its earnings are cyclical with weather and claims inflation. Three features set it apart from purely domestic peers:
-
A large, profitable specialist and reinsurance book that is already about a fifth international.
-
A fee-rich alternative risk transfer (ART) business, which delivered R944m pre-tax in FY2025.
-
A capital-efficient relationship with Sanlam, through shared IT infrastructure, distribution, asset management and joint ventures.
Earnings quality depends on catastrophe experience and reserve movements.
Business model and revenue model
| Revenue composition — operating segments FY2025 | ZAR Mn | % of operating-segment insurance revenue | Source |
|---|---|---|---|
| Conventional insurance revenue | 44,116 | 92.8 | AFS FY2025 note 2.1 |
| ART insurance revenue (shareholder-attributable) | 2,158 | 4.5 | AFS FY2025 note 2.1 |
| Other (brokerage, platforms, administration) | 57 | 0.1 | AFS FY2025 note 2.1 |
| Santam's share of Sanlam general insurance (India/Malaysia) | 1,190 | 2.5 | AFS FY2025 note 2.1 |
| Total operating-segment insurance revenue | 47,521 | 100.0 | AFS FY2025 note 2.1 |
| ART fee and other revenue (in addition to the above) | 527 | — | AFS FY2025 note 2.1 |
| IFRS group insurance revenue (including ART cells, after reallocations) | 56,127 | — | AFS FY2025 SOCI |
Santam earns three types of income:
-
Underwriting margin. Net earned premium (NEP) less claims, commission and management expenses. The target range is 5–10% of NEP.
-
Investment return on insurance funds ("float"). This was 2.6–3.0% of NEP in FY2023–FY2025.
-
Investment return on shareholders' capital, plus ART fee income and investment margin.
The revenue model is overwhelmingly premium-based, with a smaller fee-based component. There is no subscription or licensing revenue in the industrial sense.
Value-chain position
Santam operates at several points in the value chain:
Primary insurer: across personal, commercial and specialist lines.
Reinsurer,: through Santam Re (treaty), Specialist Solutions (facultative), the Lloyd's syndicate and the GIFT City International Insurance Office.
Risk-transfer platform: for corporates and affinity groups, through Centriq and SSI cell captives.
Distributor,: through Indwe Broker Holdings (100% owned since 2022), equity stakes in underwriting managers (Kern Insurance Solutions 70%; Avatar 51%), and embedded partnerships (MTN, MultiChoice/NMSIS).
It cedes risk to global reinsurers. Its reinsurance cost fell from 20.9% to 16.3% of gross earned premium between FY2023 and FY2025 (AFS FY2025).
Customer types and end-markets
| Customer / channel | Description | Evidence |
|---|---|---|
| Independent brokers | Largest distribution channel in South Africa; Santam reports a leading market share | IFS H1 2026 |
| Direct retail clients | MiWay (direct insurer) and Santam Direct; direct share 22% of GWP (FY2025), 23% (H1 2026) | AFS FY2025 scorecard; IFS H1 2026 |
| Partnership / embedded | MTN device insurance (policy count close to 600,000 in FY2025); MultiChoice subscriber base of about 8 million via NMSIS | AFS FY2025; Santam media release Nov 2024 |
| Commercial and corporate | Commercial GWP R26.4bn (60% of conventional GWP, FY2025) | AFS FY2025 note 2.1 |
| Agriculture | Crop GWP R1.35bn (FY2025); parametric smallholder product launched 2025 | AFS FY2025; IR FY2025 summary |
| Insurers / cedants | Santam Re treaty partnerships; SanlamAllianz inward reinsurance | AFS FY2025; IFS H1 2026 note 13 |
| Corporates using ART | Cell captives and mining rehabilitation guarantees; one ART client contributed R7.3bn (12.9%) of group revenue in FY2025 | AFS FY2025 note 2 |
End-markets by insurance class. Property was 45.4% of conventional GWP in FY2025 (derived). Motor was 38.3%, followed by engineering, liability, crop, transportation, and accident and health (AFS FY2025).
Strategy
Stated strategy — FutureFit 2030 (themes paraphrased)
The FY2025 AFS and H1 2026 IFS set out the following themes:
-
Strengthen leadership in South Africa, particularly in the independent broker channel, through better ease of doing business and broker value propositions (Santam CashBack).
-
Scale direct distribution, through MiWay and Santam Direct, where Santam's share is below its overall market share.
-
Grow in partnerships and under-penetrated segments, through MTN, MultiChoice and tailored solutions, framed as narrowing the protection gap.
-
Diversify internationally, via Santam Re, Specialist Solutions, the Lloyd's syndicate and GIFT City, which management says could transform the group into a global multinational insurer.
-
Maintain underwriting discipline, pricing integrity and expense efficiency, including declining uneconomically priced specialist risks.
Medium- and long-term financial targets
| Measure | Long-term target | FY2024 | FY2025 | H1 2026 | Source |
|---|---|---|---|---|---|
| Growth in size of book | CPI + GDP + 1–2% | GWP 10.5% / NEP 9.7% | GWP 6.4% / NEP 14.7% | GWP 10.1% / NEP 5.5% | AFS FY2024, FY2025; IFS H1 2026 |
| Net underwriting margin | 5–10% | 7.6% | 11.3% | 8.1% | Same |
| International diversification | >20% of GWP by 2030 (FY2024–FY2025); stated as >30% by 2030 in H1 2026 | 18% | 19% | 23% | Same |
| Direct diversification | >30% by 2030 | 17% | 22% | 23% | Same |
| Return on capital | 24% hurdle | 32% | 29.2% | 27.0% | Same |
| Dividend growth | In line with NEP growth | 8.6% | 10.5% | 10.2% | Same |
| Economic capital coverage | 145–165% | 166% | 169% | 167% | Same |
Strategic initiatives — last 24 months
| Initiative | Date | Detail / targets | Status | Source |
|---|---|---|---|---|
| Santam Syndicate 1918 (Lloyd's) | In-principle Jul 2025; live 1 Jan 2026 | Approved capacity over £300m for 2026 (about R6.5bn planned GWP); revised plan adds £67m; EPI £59m (R1.3bn) to June 2026; 2026 operating loss guided at R450–550m; monthly breakeven expected in 2027 | Operational | FY2025 booklet; IFS H1 2026; Reinsurance News |
| GIFT City IIO (India) | Licence Jan 2026; opened 1 Apr 2026 | Treaty and facultative reinsurance; improved order-of-preference status for Indian cedants | Operational | IFS H1 2026; Moonstone |
| Santam CashBack | 1 Jul 2026 | Intermediated-channel value proposition | Launched | IFS H1 2026 |
| Micashback (MiWay) | 2025–2026 | Rolled out to all personal lines; early positive effects on premium, claims and persistency | Complete | AFS FY2025; IFS H1 2026 |
| MultiChoice / NMSIS partnership | Effective 2 May 2025 | 60% of A1 shares (general insurance profits); cross-sell to about 8m subscribers | Integrating | AFS FY2025 |
| Reinsurance optimisation | 2024–2025 | Catastrophe retention raised from R505m to R1bn; reinsurance cost fell from 20.9% to 16.3% of gross earned premium | Complete | AFS FY2025 |
| Reserve prudency | 2024–2026 | Sufficiency raised from the 79th (2023) to 84th (2024) to 91st (2025) percentile, then reduced to the 87th (H1 2026) | Ongoing | AFS FY2024, FY2025; IFS H1 2026 |
| Digital strategy reset | 2,025 | Standalone digital platforms closed; collaboration with Sanlam group digital distribution | Complete | AFS FY2025 |
| Sanlam group rewards | 2,026 | Roll-out across Santam group | In progress | AFS FY2025 |
| Asset manager transition | H2 2026 | Majority of investment assets to move from Sanlam Investments to Ninety One, following a SIM–Ninety One transaction | Planned | IFS H1 2026 note 13 |
| Avatar (US mid-market MGA) | Jul 2025 → 2026 | Capacity released and resources redirected to the syndicate after US property rates fell | Scaled back | IFS H1 2026 |
| ESG: P4RR | Ongoing | Expanded to 110 municipalities (FY2025) | Ongoing | IR FY2025 summary |
| ESG: parametric agri insurance | 2,025 | First parametric agricultural product in South Africa for smallholders | Launched | IR FY2025 summary |
Management guidance (latest, H1 2026 IFS)
-
The operating environment in H2 2026 is expected to remain challenging: low growth, pressure on disposable income, investment volatility.
-
Competitive pressure in intermediated and specialty lines is expected to persist.
-
The syndicate will add growth momentum, but most additional 2026 business will be earned in 2027–2028.
-
Absent further abnormal catastrophe and large losses, the group expects to operate within the 5–10% underwriting margin range.
Products & Services
Pricing models are premium-based (risk-rated) for all underwriting products and fee- or margin-based for ART. Specific tariffs are not publicly disclosed.
Broker Solutions and Client Solutions (Santam-branded intermediated and direct)
| Product / offering | Description and capabilities | Target customer | Launch / latest | Source |
|---|---|---|---|---|
| Personal motor and household (Santam-branded) | Comprehensive and limited motor; buildings and contents; all-risks; distributed mainly through independent brokers | Middle- and upper-income households | Long-standing; underwriting actions 2023–2025 (segmented increases, higher excesses, vehicle-security requirements) | AFS FY2024 |
| Commercial lines (SME and mid-market) | Property, motor fleet, liability, business all-risks, business interruption | SMEs and mid-market businesses | Long-standing; geocoding and expanded property surveys rolled out 2024 | AFS FY2024 |
| Power surge cover modifications | Specific excesses and exclusions introduced as power-surge claims rose during load-shedding | Personal and commercial | 2022–2023 | Moonstone; AFS FY2024 |
| Santam Direct | Santam-branded direct sales channel | Retail clients preferring direct purchase | Double-digit GWP growth H1 2026 | IFS H1 2026 |
| Santam CashBack | Cashback-style value proposition under the Santam brand across intermediated channels; designed to support broker propositions and retention | Broker-sourced personal clients | Launched 1 Jul 2026 | IFS H1 2026 |
| Cyber insurance | Growing uptake reported within the liability class | Commercial clients | Growth cited 2022 | Summary AFS FY2022 |
MiWay (direct insurer)
| Product / offering | Description | Target customer | Launch / latest | Source |
|---|---|---|---|---|
| MiWay personal motor and household | Direct telephony and digital motor and home cover; outbound, inbound and tied-agency sales | Mass and middle-market consumers | Launched 2008; inbound and tied-agency strategies 2023 | Wikipedia; AFS FY2025 |
| MiWay Business Insurance | Commercial cover for small businesses sold direct | Small businesses | Reported as performing "exceptionally well" in FY2024–FY2025 | AFS FY2024, FY2025 |
| Value-added products | Ancillary covers sold alongside core policies (specific products not itemised) | MiWay clients | Strong FY2025 performance | AFS FY2025 |
| Micashback | Cashback feature on personal lines policies | MiWay personal lines clients | Launched 2025; 78% of policies active at end-2025; full roll-out 2026 | AFS FY2025; IFS H1 2026 |
Partner Solutions (embedded and affinity)
| Product / offering | Description | Target customer | Launch / latest | Source |
|---|---|---|---|---|
| MTN device insurance | Mobile device cover sold through MTN South Africa; book transferred to the Santam licence in Q1 2024; annual GWP of nearly R400m at acquisition | MTN subscribers | New sales from April 2023; policies near 600,000 (FY2025) | SENS 16 May 2023; AFS FY2024, FY2025 |
| NMSIS / MultiChoice general insurance (via 60% of A1 shares) | Device, installation, subscription-waiver, debt-waiver cover under the DStv brand (funeral cover sits in the life class); 3.3m in-force policies at 31 March 2024 | About 8m MultiChoice South African subscribers | Effective 2 May 2025 | SENS 28 Nov 2024; AFS FY2025 |
| Tailored partner solutions | Cross-sell products for partner client bases and under-insured segments | Lower-income and under-penetrated segments | In development (H1 2026) | IFS H1 2026 |
Specialist Solutions (corporate, niche and agri)
| Product / offering | Description | Target customer | Latest | Source |
|---|---|---|---|---|
| Corporate property | Large commercial property risks, including facultative; exposed to soft international pricing | Large corporates | Rates softened FY2025 | AFS FY2025 |
| Casualty / liability | General, professional and related liability lines | Corporates and professionals | Pricing pressure persisted FY2025 | AFS FY2025 |
| Engineering | Construction and engineering risks, including renewable energy projects (Mirabilis Engineering Underwriting Managers is a group subsidiary) | Contractors, project owners, energy sector | Mirabilis restructured via in-specie dividend March 2024 | AFS FY2024; summary AFS FY2022 |
| Crop and agriculture | Multi-peril and hail crop insurance; parametric agricultural cover for smallholder farmers | Commercial and emerging farmers | Parametric product launched 2025 | AFS FY2024; IR FY2025 summary |
| Marine | Cargo and hull-related marine lines | Shippers and logistics | Lower new business FY2025 | AFS FY2025 |
| Heavy haulage | Transportation of heavy loads | Logistics operators | Rate softening FY2025 | AFS FY2025 |
| Aviation | Aviation risks within the transportation class | Aviation operators | Growth cited FY2022 | Summary AFS FY2022 |
| Travel | Travel insurance within accident and health | Travellers and corporates | Growth cited FY2022 | Summary AFS FY2022 |
| Pan-African specialist (with SanlamAllianz) | Specialist business across African markets under a framework cooperation agreement | African corporates and insurers | GWP R822m (FY2023), R782m (FY2024) | AFS FY2024 |
Santam Re and international
| Product / offering | Description | Target customer | Latest | Source |
|---|---|---|---|---|
| Treaty reinsurance (Santam Re) | Non-life treaty reinsurance across property, engineering, marine, liability and motor; large partnership deals | Insurers in Africa, Middle East, Asia | Portfolio restructured 2023–2024; partnership business from 2024; Nico Conradie CEO from 1 Mar 2026 | AFS FY2024, FY2025; Reinsurance News |
| GIFT City International Insurance Office (India) | Treaty capacity mainly via Santam Re plus Specialist Solutions facultative support; writes on AM Best A- rated paper | Indian and wider Asian cedants | Licensed Jan 2026; opened 1 Apr 2026 | Moonstone; Reinsurance News; IFS H1 2026 |
| Santam Syndicate 1918 (Lloyd's) | Lloyd's syndicate writing mainly consortia and facility lines in 2026, plus treaty and facultative reinsurance; approved capacity over £300m, with a revised 2026 plan adding £67m | Global brokers and clients in the Lloyd's market | Underwriting from 1 Jan 2026; CEO Sam Geddes (2026) | FY2025 results booklet; IFS H1 2026; Reinsurance News |
| Avatar Holdings (51%) | UK-based technology-led underwriting start-up for mid-sized US corporate risks | US mid-market corporates | Acquired July 2025; capacity released back to providers in 2026 as US property rates fell | AFS FY2025; IFS H1 2026 |
Alternative risk transfer (ART)
| Product / offering | Description | Target customer | Latest | Source |
|---|---|---|---|---|
| Centriq cell captives (Centriq Insurance Company, Centriq Life) | First- and third-party cell captive structures; Santam earns administration fees and investment margin and may participate in underwriting | Corporates, affinity groups, UMAs | — | AFS FY2025 audit committee report |
| Santam Structured Insurance (SSI) and Santam Structured Life | Structured and finite insurance, including mining rehabilitation guarantees | Mining and large corporates | Significant mining rehabilitation premiums from FY2022 | Summary AFS FY2022 |
| ART underwriting participation | Discretionary participation in reinsurance placed by cells | — | Underwriting profit R197m (FY2024) | AFS FY2024 |
Other and distribution
| Offering | Description | Latest | Source |
|---|---|---|---|
| Indwe Broker Holdings | Wholly owned insurance brokerage | 100% since May 2022 | Summary AFS FY2022 |
| Kern Insurance Solutions Consult (70%) | Insurance solutions business | Acquired March 2025 for R19.6m plus contingent R4.9m | AFS FY2025 |
| Santam digital platforms | Standalone digital ventures | Closed and impaired in 2025; strategy shifted to Sanlam group digital distribution | AFS FY2025 |
| Sanlam group rewards participation | Shared rewards programme | Roll-out across Santam group during 2026 | AFS FY2025 |
Financial Narrative
Conventional insurance — top line and underwriting (management basis)
Source: summary AFS FY2022 note 6.2 (FY2021–FY2022, IFRS 4 basis); AFS FY2024 note 2.1 (FY2023); AFS FY2025 note 2.1 (FY2024–FY2025).
Source: AFS FY2024 and FY2025 (FY2023–FY2025 ratios as reported). FY2021–FY2022 ratios derived from the summary AFS FY2022; the company reported FY2022 adjusted ratios excluding reinstatement premiums (net commission 13.3%, management expense 16.5%). FY2021 GWP growth as reported (5%).
Commentary — top line. Conventional GWP grew at a 7.6% CAGR from FY2021 to FY2025 and NEP at 9.3% (derived). Both are at or above the company's target of CPI + GDP + 1–2%.
FY2024: 10.5% GWP growth came mainly from rate strengthening in property after years of losses, the MTN book transfer, and Santam Re's restructured portfolio.
FY2025: NEP grew 14.7% while GWP grew only 6.4%. The company attributes the gap to large Santam Re partnership deals with a different premium-recognition profile and lower reinsurance needs. It says these deals are now fully in the base, so NEP growth should follow GWP more closely.
H1 2026: GWP +10% but NEP only +6%. This reflects deferred earning on syndicate, specialist and reinsurance business.
Commentary — underwriting. The margin path was:
FY2021 (8.0%): recovery after COVID.
FY2022 (5.1%): KZN floods, claims inflation, fire and power-surge losses, partly offset by R714m of CBI provision releases.
FY2023 (3.5%): weather and large losses of about R1.3bn, Turkey earthquake exposure, and run-off losses on cancelled international business.
FY2024 (7.6%): and FY2025 (11.3%): underwriting actions took effect and weather losses fell by about R600m.
The FY2025 margin also absorbed a R900m strengthening of reserve prudency, from the 84th to the 91st percentile, so underlying profitability was stronger than reported. Reserve movements cut both ways, however. In H1 2026 the margin of 8.1% included a R325m earnings benefit from lowering reserve sufficiency from the 91st to the 87th percentile. This is a quality-of-earnings point analysts should note.
Commentary — expenses. The management expense ratio rose from 16.5% (FY2023) to 19.0% (FY2025). The company attributes the increase as follows:
-
Profit-share arrangements with MTN and MultiChoice, booked as expenses: +1.0pt.
-
MiWay growth investment and sales-related costs: +2.1pt.
-
Variable remuneration: +0.7pt.
-
Efficiency gains: −1.3pt.
(AFS FY2025.)
Group income statement (IFRS)
Source: summary AFS FY2022 (FY2021–FY2022 IFRS 4); AFS FY2024 (FY2023); AFS FY2025 (FY2024–FY2025). FY2023 net income includes R705m profit from discontinued operations (SAN JV). FY2023 PBT shown is continuing operations.
Not applicable to insurers. Gross profit, operating income (industrial definition) and EBITDA are not reported and are not meaningful for a general insurer. The insurance service result, net underwriting result and net insurance result above are the relevant substitutes. EBITDA-based ratios (net debt/EBITDA, EV/EBITDA) are therefore marked not applicable throughout.
Earnings bridge (shareholder basis)
Source: AFS FY2024 and FY2025 Directors' reports. FY2023 "Other" of R673m includes the R705m discontinued profit; associates and amortisation lines shown separately. FY2025 investment return on capital was depressed by R1bn of foreign-currency losses (including R420m on the SGI investment) and a R132m write-down of Pacific & Orient to nil. Amortisation and other in FY2025 includes R325m one-off syndicate set-up and digital-closure costs.
Per-share data
Source:
-
EPS: summary AFS FY2022 (FY2021–FY2022); AFS FY2024 (FY2023); AFS FY2025 (FY2024–FY2025).
-
DPS: summary AFS FY2022; AFS FY2024; AFS FY2025.
-
Payout ratio derived.
Source: interim report H1 2023 (H1 2022 restated IFRS 17 comparatives); IFS H1 2026.
Balance sheet
Source: summary AFS FY2022 (FY2021–FY2022 IFRS 4); AFS FY2024 (FY2023); AFS FY2025 (FY2024–FY2025). Net debt derived; negative means net cash. Cash includes policyholder/cell balances, so a "net debt" concept has limited meaning for an insurer. Short-term vs long-term debt split: all debt securities are long-dated subordinated notes, so the short-term debt component is nil (repo liabilities of R1,025m in FY2025 relate to cell portfolios). Working capital is not applicable (unclassified insurer balance sheet). The IFRS 17 restated opening shareholders' equity at 1 January 2023 was R10,864m (vs R10,929m under IFRS 4).
Source: IFS H1 2026. Of total assets at 30 June 2026, R42.2bn related to policyholders and cell owners and R43.6bn to shareholders (IFS H1 2026 note 15).
Cash flow
Source: summary AFS FY2022; AFS FY2024; AFS FY2025. Free cash flow derived. Net cash from operating activities is after net investment of insurance float into financial assets (FY2025: −R8,321m), which makes it a volatile FCF measure. Santam has no formal share buyback programme; treasury purchases fund share incentive schemes. A general repurchase authority is renewed at each AGM (AFS FY2025).
Ratios
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment (IFRS 8) Overview
| Segment (IFRS 8) | Contents | Products / businesses |
|---|---|---|
Conventional insurance | Business written on Santam-controlled licences | Broker Solutions, Client Solutions (including Santam Direct), Partner Solutions (MTN, NMSIS/MultiChoice), Specialist Solutions (including Santam Syndicate 1918 and related entities), MiWay, Santam Re (including the GIFT City IIO). Analysed further into commercial vs personal, by insurance class, and (from H1 2026) by geography |
Alternative risk transfer (ART) | Business on the licences of the Centriq Insurance group and the Santam Structured Insurance group | First- and third-party cell captives, structured insurance, mining rehabilitation guarantees, Centriq Life, Santam Structured Life |
Other | Businesses not bearing insurance risk for own account | Brokerage (Indwe), platforms, administration; amortisation/impairment of intangibles; associates |
Santam's share of Sanlam general insurance businesses | Economic participation via Sanlam target shares in SGI (India) and Pacific & Orient (Malaysia) | Reported as a segment in FY2023–FY2025. Removed from the main segment analysis from H1 2026 and shown in a supplementary note |
Segment insurance revenue (ZAR Mn)
| Segment insurance revenue (ZAR Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Conventional | 36,042 | 39,730 | 44,116 |
Alternative risk transfer | 1,487 | 2,101 | 2,158 |
Other | 0 | 55 | 57 |
Sanlam general insurance share | 937 | 1,160 | 1,190 |
Total operating segments | 38,466 | 43,046 | 47,521 |
Segment profit before tax (ZAR Mn)
| Segment profit before tax (ZAR Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Conventional | 2,910 | 4,604 | 5,312 |
Alternative risk transfer | 516 | 781 | 944 |
Other (continuing) | -32 | -244 | -457 |
Total operating segments (continuing) | 3,394 | 5,141 | 5,799 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Segment analytics (%) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Conventional PBT margin on segment revenue | 8.1 | 11.6 | 12.0 |
Conventional revenue growth YoY | — | 10.2 | 11.0 |
ART revenue growth YoY | — | 41.3 | 2.7 |
ART PBT growth YoY | — | 51.4 | 20.9 |
Conventional share of operating-segment revenue | 93.7 | 92.3 | 92.8 |
ART share of operating-segment revenue | 3.9 | 4.9 | 4.5 |
Conventional share of operating-segment PBT | 85.7 | 89.6 | 91.6 |
Revenue by Segment
| Conventional by line (ZAR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Commercial GWP | 19,206 | 21,327 | 22,519 | 24,435 | 26,406 |
Personal GWP | 13,539 | 14,091 | 14,849 | 16,873 | 17,554 |
Commercial underwriting result | 1,126 | 1,223 | 1,053 | 1,518 | 2,285 |
Personal underwriting result | 938 | 166 | -22 | 923 | 1,875 |
Commercial NEP | — | — | 16,593 | 17,544 | 20,558 |
Personal NEP | — | — | 12,742 | 14,648 | 16,362 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment (Half-Yearly)
| Conventional by line (ZAR Mn) | H1 2025 | H1 2026 |
|---|---|---|
Commercial GWP | 12,429 | 13,876 |
Personal GWP | 8,515 | 9,177 |
Commercial underwriting result | 1,164 | 186 |
Personal underwriting result | 861 | 1,350 |
Revenue by Segment and Segment Assets & Liabilities
| Conventional GWP by class (ZAR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Property | 12,177 | 13,194 | 14,076 | 15,435 | 19,970 |
Motor | 14,412 | 15,124 | 15,738 | 16,786 | 16,817 |
Engineering | 1,730 | 1,759 | 2,024 | 2,526 | 2,055 |
Liability | 1,550 | 1,743 | 1,967 | 2,804 | 1,842 |
Crop | 1,130 | 1,556 | 1,525 | 1,345 | 1,351 |
Transportation | 994 | 1,174 | 1,371 | 1,673 | 1,194 |
Accident and health | 572 | 719 | 572 | 653 | 720 |
Other (including guarantee and miscellaneous) | 180 | 149 | 95 | 86 | 11 |
Business Units
| Business unit | FY2025 performance disclosed | H1 2026 performance disclosed | Source |
|---|---|---|---|
Broker Solutions / Client Solutions | Solid GWP growth despite moderating rates; robust underwriting; persistency improved | Solid GWP growth; competitive pressure in outsourced business; Santam CashBack rolled out 1 July 2026 | AFS FY2025; IFS H1 2026 |
Partner Solutions | Strong growth; MultiChoice book included from May 2025; MTN policies near 600,000 | Good growth (base effect of MultiChoice); double-digit GWP growth | AFS FY2025; IFS H1 2026 |
MiWay | GWP +15% (FY2024: +8%); underwriting margin 8.3%; record new business; Micashback active on 78% of policies at year-end | GWP +13%; Micashback rolled out to all personal lines | AFS FY2025; IFS H1 2026 |
Specialist Solutions | GWP declined marginally; casualty pricing pressure; corporate property and heavy haulage rates softened; "superior" underwriting results | Double-digit GWP growth including syndicate; growth positive excluding syndicate | AFS FY2025; IFS H1 2026 |
Santam Re | Targeted volumes achieved, broadly flat on FY2024 after restructuring | Strong double-digit GWP growth from new and expanded partnerships | AFS FY2025; IFS H1 2026 |
Santam Syndicate 1918 | Launch costs within the R325m one-off expenses | EPI R1.3bn (about £59m); GWP recognised R461m; NEP R87m; underwriting loss R230m | AFS FY2025; IFS H1 2026; Reinsurance News |
Key Financials and Returns & Leverage Ratios (%)
| Conventional insurance (ZAR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross written premium | 32,745 | 35,418 | 37,368 | 41,308 | 43,960 |
Net earned premium | 25,858 | 27,221 | 29,335 | 32,192 | 36,920 |
Net claims incurred | 16,023 | 17,588 | 19,420 | 19,657 | 20,657 |
Net commission | 3,458 | 3,661 | 4,049 | 4,270 | 5,073 |
Management expenses | 4,313 | 4,583 | 4,835 | 5,824 | 7,030 |
Net underwriting result | 2,064 | 1,389 | 1,031 | 2,441 | 4,160 |
Investment return on insurance funds | 400 | 341 | 759 | 823 | 1,095 |
Net insurance result | 2,464 | 1,730 | 1,790 | 3,264 | 5,255 |
Conventional insurance ratios (% of NEP)
| Conventional insurance ratios (% of NEP) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Net claims ratio | 62.0 | 64.6 | 66.2 | 61.1 | 56.0 |
Net commission ratio | 13.4 | 13.4 | 13.8 | 13.2 | 13.7 |
Management expense ratio | 16.7 | 16.8 | 16.5 | 18.1 | 19.0 |
Combined ratio | 92.0 | 94.9 | 96.5 | 92.4 | 88.7 |
Net underwriting margin | 8.0 | 5.1 | 3.5 | 7.6 | 11.3 |
Net insurance margin | 9.5 | 6.4 | 6.1 | 10.2 | 14.3 |
GWP growth YoY | 5.0 | 8.2 | 5.5 | 10.5 | 6.4 |
NEP growth YoY | — | 5.3 | 7.8 | 9.7 | 14.7 |
Group income statement (ZAR Mn)
| Group income statement (ZAR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Insurance revenue (IFRS 17) | — | — | 46,882 | 52,317 | 56,127 |
Group gross written premium (IFRS 4) | 42,129 | 49,627 | — | — | — |
Insurance service result (IFRS 17) | — | — | 2,817 | 4,512 | 7,048 |
Net investment income and other revenue (IFRS 17) | — | — | 5,029 | 6,142 | 5,732 |
Result of operating activities | 3,958 | 3,003 | 4,504 | 6,094 | 7,909 |
Profit before tax (IFRS, including cell owners) | 4,307 | 3,497 | 4,405 | 5,952 | 7,830 |
Income before tax and NCI (shareholder basis) | — | — | 4,099 | 5,141 | 5,799 |
Net income attributable to equity holders | 2,745 | 1,990 | 3,250 | 3,679 | 4,059 |
Non-controlling interest share of profit | 99 | 99 | 133 | 677 | 1,011 |
Earnings bridge (ZAR Mn)
| Earnings bridge (ZAR Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Conventional net insurance result | 1,790 | 3,264 | 5,255 |
Investment return on capital (conventional) | 1,120 | 1,340 | 57 |
ART net income | 516 | 781 | 944 |
Associated companies | 81 | 88 | 147 |
Amortisation and other | -113 | -332 | -604 |
Income before tax and NCI | 4,099 | 5,141 | 5,799 |
Tax and NCI | -849 | -1,462 | -1,740 |
Net income | 3,250 | 3,679 | 4,059 |
Per-share data (ZAR cents)
| Per-share data (ZAR cents) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Basic EPS | 2,491 | 1,816 | 2,973 | 3,356 | 3,717 |
Diluted EPS | 2,478 | 1,803 | 2,952 | 3,322 | 3,678 |
Headline EPS | 2,495 | 1,826 | 2,310 | 3,477 | 3,743 |
Ordinary DPS | 1,222 | 1,307 | 1,400 | 1,520 | 1,680 |
Special DPS | 800 | 0 | 1,780 | 0 | 0 |
Ordinary payout ratio on basic EPS (%) | 49 | 72 | 47 | 45 | 45 |
Interim per-share data (ZAR cents)
| Interim per-share data (ZAR cents) | H1 2022 | H1 2023 | H1 2025 | H1 2026 |
|---|---|---|---|---|
Basic EPS | 490 | 1,170 | 1,873 | 2,006 |
Headline EPS | 475 | 1,170 | 1,873 | 2,006 |
Interim DPS | 462 | 495 | 590 | 650 |
Balance Sheet
| Balance sheet (ZAR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets | 65,558 | 73,047 | 67,130 | 73,439 | 82,392 |
Cash and cash equivalents | 4,496 | 5,387 | 4,819 | 6,385 | 6,083 |
Financial assets at fair value through P&L | 31,047 | 35,850 | 43,748 | 51,773 | 61,904 |
Strategic investments in unlisted shares | 1,691 | 1,596 | 2,030 | 2,483 | 3,179 |
Intangible assets (including goodwill) | 989 | 1,073 | 1,226 | 996 | 985 |
Debt securities (subordinated notes) | 2,552 | 2,539 | 3,053 | 3,063 | 4,088 |
Lease liabilities | 764 | 669 | 824 | 786 | 834 |
Shareholders' equity (attributable) | 11,432 | 10,929 | 10,692 | 12,736 | 15,047 |
Total equity | 12,062 | 11,598 | 11,406 | 14,075 | 16,579 |
Net debt (debt securities less cash) | -1,944 | -2,848 | -1,766 | -3,322 | -1,995 |
Balance Sheet (31 Dec 2025–30 Jun 2026)
| Balance sheet (ZAR Mn) | 31 Dec 2025 | 30 Jun 2026 |
|---|---|---|
Total assets | 82,392 | 85,736 |
Cash and cash equivalents | 6,083 | 6,498 |
Debt securities | 4,088 | 4,098 |
Shareholders' equity | 15,047 | 15,896 |
Total equity | 16,579 | 17,441 |
Net insurance contract liabilities | 42,135 | 43,385 |
Cash flow (ZAR Mn)
| Cash flow (ZAR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cash generated from operations | 3,279 | 9,624 | 5,860 | 8,470 | 9,632 |
Net cash from operating activities | 1,884 | 3,543 | 667 | 3,680 | 2,448 |
Capex (equipment plus intangibles) | 108 | 136 | 271 | 119 | 95 |
Free cash flow (operating less capex) | 1,776 | 3,407 | 396 | 3,561 | 2,353 |
Dividends paid to shareholders | 477 | 2,264 | 3,424 | 1,576 | 1,679 |
Treasury share purchases | 120 | 237 | 221 | 161 | 145 |
Key ratios
| Key ratios | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Return on capital as reported (%) | 28.5 | 18.8 | 28.5 | 31.9 | 29.2 |
ROE on average shareholders' equity (%) | — | 17.8 | 30.2 | 31.4 | 29.2 |
ROA on year-end total assets (%) | 4.2 | 2.7 | 4.8 | 5.0 | 4.9 |
Debt securities / shareholders' equity (x) | 0.22 | 0.23 | 0.29 | 0.24 | 0.27 |
Interest coverage (PBT plus finance costs / finance costs) (x) | 14.8 | 11.8 | 11.1 | 12.1 | 16.3 |
Asset turnover (insurance revenue / total assets) (x) | — | — | 0.70 | 0.71 | 0.68 |
Economic capital coverage ratio (%) | 169 | 156 | 155 | 166 | 169 |
Net income margin on insurance revenue (%) | — | — | 6.9 | 7.0 | 7.2 |
Key Financials
| Capital (ZAR Bn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Economic capital requirement | 8.3 | 8.6 | 8.8 | 9.5 | 11.3 |
Available economic capital | 13.9 | 13.5 | 13.7 | 15.8 | 19.1 |
Growth metric
| Growth metric | Value | Basis | Source |
|---|---|---|---|
Conventional GWP CAGR FY2021–FY2025 | 7.6% | 32,745 → 43,960 | Derived |
Conventional NEP CAGR FY2021–FY2025 | 9.3% | 25,858 → 36,920 | Derived |
Insurance revenue CAGR FY2023–FY2025 (IFRS 17) | 9.4% | 46,882 → 56,127 | Derived |
Net income CAGR FY2021–FY2025 | 10.3% | 2,745 → 4,059 | Derived |
Ordinary DPS CAGR FY2021–FY2025 | 8.3% | 1,222 → 1,680 | Derived |
Key Financials (Half-Yearly)
| Interim conventional business (ZAR Mn) | H1 2022 | H1 2023 | H1 2024 | H1 2025 | H1 2026 |
|---|---|---|---|---|---|
Gross written premium | 16,543 | 17,657 | 19,084 | 20,944 | 23,053 |
Net earned premium | 13,496 | 14,377 | 15,395 | 17,920 | 18,906 |
Revenue by Region
| Conventional GWP by geography (ZAR Bn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
South Africa | 27.5 | 30.0 | 31.5 | 33.9 | 35.5 |
Outside South Africa | 5.3 | 5.5 | 5.8 | 7.4 | 8.4 |
Revenue by Region (%) and Region Margins & Growth (%)
| Conventional GWP mix (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
South Africa share | 84 | 85 | 84 | 82 | 81 |
Outside South Africa share | 16 | 15 | 16 | 18 | 19 |
Outside South Africa growth YoY | — | 3 | 6 | 28 | 14 |
Insurance revenue by geography (ZAR Mn)
| Insurance revenue by geography (ZAR Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
South Africa | 32,648 | 36,076 | 37,931 |
Rest of Africa | 2,533 | 2,614 | 2,767 |
Other international | 4,138 | 4,356 | 6,823 |
Of which Santam Namibia (included in Rest of Africa) | 1,088 | 1,235 | 1,447 |
Conventional H1 2026 by Region Details
| Conventional H1 2026 by region (ZAR Mn) | GWP | NEP | Net underwriting result | Net insurance result |
|---|---|---|---|---|
South Africa | 17,781 | 15,731 | 1,611 | 2,068 |
International total | 5,272 | 3,175 | -75 | 10 |
of which Syndicate 1918 and related | 461 | 87 | -230 | -229 |
of which Treaty reinsurance | 3,178 | 2,340 | -35 | 23 |
of which Other international | 1,633 | 748 | 190 | 216 |
Conventional H1 2025 by region (ZAR Mn) | GWP | NEP | Net underwriting result | Net insurance result |
South Africa | 16,719 | 14,694 | 1,836 | 2,230 |
International total | 4,225 | 3,226 | 189 | 261 |
of which Treaty reinsurance | 2,736 | 2,533 | 39 | 83 |
of which Other international | 1,489 | 693 | 150 | 178 |
Country / Region Details
| Country / region | Disclosure | Source |
|---|---|---|
South Africa | 77–85% of conventional GWP over the period | AFS FY2022–FY2025; IFS H1 2026 |
Namibia | Santam Namibia Ltd insurance revenue R1,447m (FY2025), R776m (H1 2026) | AFS FY2025; IFS H1 2026 |
India | 14% effective economic share of SGI. SGI GWP grew 27% in FY2025 and 20% in rupees in the H1 2026 lag period; underwriting margin improved from 1.7% to 5.9%. Santam's share of Sanlam GI (India and Malaysia) GWP was R760m in H1 2026, reported with a 3-month lag | AFS FY2025; IFS H1 2026 note 5.3 |
Malaysia | Pacific & Orient written down to nil after a R132m fair value loss in FY2025 | AFS FY2025 |
UK / Lloyd's | Syndicate 1918 GWP R461m recognised in H1 2026 (EPI R1.3bn) | IFS H1 2026 |
Rest of Africa (with SanlamAllianz) | Specialist GWP R822m (FY2023) and R782m (FY2024) | AFS FY2024 |
Middle East | Santam Re growth cited in FY2022; country split not disclosed | Summary AFS FY2022 |
Share price (ZAR)
| Share price (ZAR) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Year-end close | 269.00 | 256.45 | 286.57 | 392.64 | 427.45 |
Year high | 289.00 | 315.99 | 316.00 | 406.96 | 449.94 |
Year low | 231.37 | 228.56 | 245.04 | 276.98 | 341.82 |
Start by Period
| Period | Start | End | Change |
|---|---|---|---|
~1 year: end-2025 to pre-offer | 427.45 | 399.75 (2 Oct 2026) | −6.5% |
~1 year: end-2025 to post-offer | 427.45 | 475.00 (5 Oct 2026) | +11.1% |
~3 years: end-2023 to post-offer | 286.57 | 475.00 | +65.8% |
~5 years: end-2021 to post-offer | 269.00 | 475.00 | +76.6% |
Offer price vs end-2021 | 269.00 | 505.00 | +87.7% |
Valuation Multiples
| Multiple | At R399.75 (pre-offer) | At R475.00 (5 Oct 2026) | At R505 (offer) | Basis |
|---|---|---|---|---|
P/E, FY2025 basic EPS (3,717c) | 10.8x | 12.8x | 13.6x | AFS FY2025 |
P/E, trailing 12 months (H2 2025 + H1 2026 EPS = 3,850c) | 10.4x | 12.3x | 13.1x | Derived |
P/B, NAV per share about R145.5 (30 Jun 2026; 15,896 / about 109.2m shares net of treasury) | 2.7x | 3.3x | 3.5x | Derived |
Trailing dividend yield (1,090c + 650c = 1,740c) | 4.4% | 3.7% | 3.4% | Derived |
Market cap / FY2025 conventional GWP | about 1.0x | about 1.2x | about 1.3x | Derived (issued-share basis) |
EV/EBITDA, EV/Sales | Not applicable to insurers | — | — | — |
Dividends per share (ZAR cents)
| Dividends per share (ZAR cents) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Interim | 432 | 462 | 495 | 535 | 590 |
Final | 790 | 845 | 905 | 985 | 1,090 |
Special | 800 | 0 | 1,780 | 0 | 0 |
Total ordinary | 1,222 | 1,307 | 1,400 | 1,520 | 1,680 |
Credit Ratings
| Agency | Rating | Scope | Date | Source |
|---|---|---|---|---|
AM Best | A- (Excellent) | Financial strength, international | Assigned Dec 2024; reaffirmed Dec 2025 | IFS H1 2026 |
S&P Global | zaAAA | National scale | Dec 2024; reaffirmed Dec 2025 | IFS H1 2026 |
S&P Global (historical) | BB | International scale (sovereign-constrained) | Reaffirmed Nov 2022 | Summary AFS FY2022 |
Capital Instruments
| Instrument | Amount (ZAR Mn) | Pricing | Call / maturity | Source |
|---|---|---|---|---|
Subordinated FRN (May 2022) | 1,000 | 3m JIBAR + 159bp | Optional redemption 16 May 2027; final 16 May 2032 | Summary AFS FY2022 |
Subordinated FRN (Apr 2023) | 1,000 | — | — | SENS 16 May 2023 |
Subordinated FRN 5-year (Oct 2025) | 1,530 | JIBAR + 120bp | Maturity 6 Oct 2030 per AFS | AFS FY2025 |
Subordinated FRN 7-year (Oct 2025) | 470 | JIBAR + 129bp | Maturity 6 Oct 2032 per AFS | AFS FY2025 |
Total subordinated notes | 4,000 (fair value R4,098m at 30 Jun 2026) | — | — | IFS H1 2026 |
Letter-of-credit facility (Funds at Lloyd's) | USD50m | 123bp commission | Expires 10 Mar 2027 | IFS H1 2026 note 6.4 |
Analyst Conclusions
Management guidance (H1 2026 IFS, 3 September 2026)
-
UWM within 5–10% for FY2026, absent further abnormal catastrophe and large losses.
-
Syndicate 1918 FY2026 operating loss of about R450–550m. Earned revenue from 2026 underwriting will be recognised mainly in 2027–2028. Monthly breakeven expected in 2027.
-
Competitive pressure persisting in intermediated and specialty lines.
-
Macro conditions challenging: low growth, pressure on disposable income, market volatility.
Consensus growth expectations
Simply Wall St (September 2026) shows a consensus target of R503.51 and forecast revenue growth of about 17.8% per year. These are secondary figures. A verified broker consensus for FY2026–FY2027 EPS is not publicly available in the sources reviewed. After the 5 October 2026 offer, the market price is anchored to the R505 cash consideration.
Bull case (grounded in data)
-
Underwriting quality is structural, not cyclical. Personal lines moved from a −R22m underwriting result (FY2023) to R1,875m (FY2025) and R1,350m (H1 2026). The property book stayed profitable despite R1.5bn of catastrophe and large losses in H1 2026.
-
International build-out reaches scale. The syndicate wrote R1.3bn EPI in six months with extra Lloyd's capacity approved. Combined with GIFT City and Santam Re partnerships (+16% treaty GWP in H1 2026), the international share could exceed 30% by 2030.
-
Capital generation remains strong. Return on capital has been at or above 27% for three-plus years, economic capital coverage is above target (167–169%), and the ART business compounds fees (PBT +21% in FY2025, +12% in H1 2026).
Bear case (grounded in data)
-
FY2025 was a peak. Weather losses were about R600m lower than in FY2024. H1 2026 already shows the margin falling from 11.3% to 8.1%, and that figure was helped by a R325m reserve release.
-
Investment-led earnings quality. H1 2026 net income growth (+7%) depended on a R727m investment return on capital, including a one-off R590m SGI revaluation, while the conventional net insurance result fell 17%.
-
Execution and cost drag. The expense ratio rose to 19.0%. The syndicate will lose up to R550m in FY2026, Avatar was paused within a year, and international treaty run-off losses recurred.
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing |
|---|---|
| Scheme circular, independent expert fairness opinion, and voting mechanics (including whether Sanlam-held shares are excluded from approval thresholds) | Oct–Nov 2026 |
| Scheme general meeting | About 30 Nov 2026 |
| Regulatory approvals (Prudential Authority, Competition authorities as applicable, Takeover Regulation Panel); implementation and delisting from JSE, NSX and A2X | Targeted Q1 2027 |
| South African summer hail and storm season (Gauteng) | Q4 2026–Q1 2027 |
| FY2026 results: syndicate loss vs R450–550m guidance; UWM within range; reserve percentile | About Mar 2027 (if still listed) |
| Ninety One asset-transfer execution; Santam CashBack and Micashback effects on retention | H2 2026–2027 |
| USD50m Funds at Lloyd's facility renewal | By Mar 2027 |
| Next subordinated debt call | May 2027 |
Analyst verdict
Santam enters late 2026 as a high-quality, well-capitalised market leader whose investment case has been overtaken by corporate action. Operationally, the company is in good shape:
-
It lifted its underwriting margin from 3.5% to 11.3% between FY2023 and FY2025 by repricing property and motor, restructuring Santam Re and optimising reinsurance.
-
It delivered returns on capital of about 29–32% against a 24% hurdle.
-
It ended FY2025 with economic capital coverage above its target range.
The H1 2026 interim results show the limits of that recovery. The catastrophe environment normalised sharply, the underwriting margin fell to 8.1% with help from a reserve release, and headline earnings growth depended on a one-off revaluation of the SGI stake. The international strategy is credible but early-stage:
-
The Lloyd's syndicate has attracted business quickly, but under IFRS revenue timing it will be loss-making in 2026.
-
GIFT City has only just opened.
-
The record of smaller international bets (Pacific & Orient, Avatar, cancelled treaty business) is mixed.
Against this, Sanlam's R505 cash offer is pivotal. It values Santam at about 13.1x trailing earnings and about 3.5x June 2026 net asset value. It is a 26.6% premium to the undisturbed price and above the previous record high, and Santam's independent board has recommended it. The offer appears to capture most of the near-term value from the current margin cycle. It also transfers the J-curve risk of the international build-out, and the catastrophe volatility, to Sanlam. Minority shareholders' main considerations will be the independent expert's fair-and-reasonable opinion, the voting mechanics, and the low probability of a competing bid given Sanlam's controlling stake.
If the scheme is implemented in Q1 2027, Santam will continue as Sanlam's general insurance platform rather than a separately investable equity. Its strategic importance within Sanlam will rise, but public disclosure will fall. Until then, the share should trade on scheme spread, with weather events and the regulatory timetable as the main sources of uncertainty.
End of dossier. Figures labelled "derived" are analyst calculations from cited company disclosures. Secondary-source data (Simply Wall St, PitchBook, GlobalData, Tracenable, Profile's Stock Exchange Handbook, Zonebourse) are flagged and should be verified against primary filings before investment or transaction use.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Classification | Committees / notes | Source |
|---|---|---|---|---|
NT Moholi | Chairperson | Independent non-executive | Board chair; nominations and other committees | IFS H1 2026 |
MP Fandeso | Lead independent director | Independent non-executive | Audit; three other committees | IFS H1 2026 |
CD da Silva | Director | Independent non-executive | Three committees | IFS H1 2026 |
M Fleming | Director | Independent non-executive | Audit, risk. Appointed 19 Jun 2026; former CFO of Clicks Group and Tiger Brands; CA(SA) | SENS 23 Jun 2026 |
DEH Loxton | Director | Independent non-executive | Audit; other committees | AFS FY2025 |
JJ Ngulube | Director | Independent non-executive (reclassified 1 Dec 2024) | One committee | AFS FY2024 |
RA Stuchbery | Director | Independent non-executive | Risk. Appointed 1 Sep 2025 | AFS FY2025 |
LA Swartz | Director | Independent non-executive | Social, ethics and sustainability; one other | AFS FY2024 |
RJ Wainwright | Director; audit committee chair from 5 Jun 2026 | Independent non-executive | Audit (chair), risk. Appointed 20 May 2025; SENS cites a CEO tenure at Investec from 2016 to 2024; CA | SENS 8 Jun 2026 |
PB Hanratty | Director | Non-executive (Sanlam Group CEO) | Two committees | IFS H1 2026; EWN |
MM Mahlangeni | Director | Non-executive | Risk. Appointed 12 Dec 2022 | Summary AFS FY2022 |
AM Mukhuba | Director | Non-executive | Two committees | IFS H1 2026 |
TC Madzinga | Group CEO | Executive | Risk, investment, social/ethics | IFS H1 2026 |
ML (Wikus) Olivier | Group CFO | Executive | Two committees | IFS H1 2026 |
Board & Management Changes
| Date | Change |
|---|---|
14 Oct 2024 | M Chauke resigned (moved to a Sanlam executive role) |
1 Dec 2024 | JJ Ngulube reclassified as independent |
20 May 2025 | RJ Wainwright appointed |
1 Sep 2025 | RA Stuchbery appointed |
5 Jun 2026 | PE Speckmann retired (on the board since 2017; audit chair) |
19 Jun 2026 | M Fleming appointed |
Executive Leadership Team
| Executive | Title | Tenure | Prior roles / education | Source |
|---|---|---|---|---|
Tavaziva (Tava) Madzinga | Group CEO and executive director | Board 1 Apr 2022; CEO since 1 Jul 2022 | CEO Britam Holdings (Nairobi); Chief Executive Swiss Re UK & Ireland; senior Old Mutual roles (Southern and East Africa, Nigeria). BBusSc Actuarial Science (UCT); MSc Data Science (University of London); INSEAD and Harvard executive programmes; FASSA, FIA. Age about 47 (GlobalData) | Santam website; GlobalData |
ML (Wikus) Olivier | Group CFO and finance director | Since 1 Jul 2023 | CA(SA); described in media as a former Sanlam executive | Santam website; Financial Mail (Apr 2025) |
Philile Mkhize | Chief Operating Officer | — | — | GlobalData |
Gareth Beaver | CEO, Santam Specialist Solutions | — | Syndicate CEO reports to him | Santam media release (2026) |
Nico Conradie | CEO, Santam Re | From 1 Mar 2026 | Former CEO of Munich Re's Africa branch; previously led Hannover Life Re Africa; MSc (North-West University); BSc Hons (Stellenbosch) | Reinsurance News; Financial Afrik |
Kush Padia | CFO, Santam Re (interim CEO before Conradie) | — | — | Reinsurance News |
Gugu Mtetwa | CEO, Santam Partner Solutions (as quoted Sep 2026) | Predecessor Tapon Njamo quoted as Partner Solutions CEO in Nov 2024 | — | EWN (Sep 2026); Santam media release (Nov 2024) |
Sam Geddes | CEO, Santam Syndicate 1918 | — | Ex-MS Amlin deputy chief underwriting officer; over 25 years in the Lloyd's market | Santam media release |
Rob Vetch | CFO, Santam Syndicate 1918 (interim CEO before Geddes) | 2025– | Ex-CFO Hamilton Global Specialty; ex-CFO W/R/B Underwriting | Reinsurance News |
Simon Clapham | CUO and active underwriter, Syndicate 1918 | 2025– | Co-founder of Avatar; ex-Brit underwriter | Business Insurance |
Directors' Remuneration
| Executive | FY | Total remuneration (ZAR Mn) | Mix | Source |
|---|---|---|---|---|
T Madzinga (CEO) | FY2024 | about 23.4 | Salary about R8.0m (about 34%); about 66% variable/long-term | Simply Wall St (secondary) |
T Madzinga (CEO) | FY2025 | about 24.6 | About 34.6% fixed / 65.4% variable | Simply Wall St (secondary) |
L Lambrechts (former CEO) | FY2021 | 17.5 | Including R8.1m performance bonus | — |
ML Olivier (CFO) | FY2025 | — | — | — |
“—” = not publicly disclosed.
Major Shareholders
| Holder | Stake | Source |
|---|---|---|
Sanlam Life Insurance Ltd (Sanlam Ltd) | 62.3% effective, excluding treasury shares; 59.1% of issued shares (30 Jun 2026); 62.7% cited as at 18 Sep 2026 | IFS H1 2026 note 13; joint SENS 5 Oct 2026 (via media) |
Treasury shares (group subsidiaries and Emthunzini BBBEE staff trust) | About 5.9m shares (about 5.1% of issued) | AFS FY2025 |
Public / institutional free float | About 37–41% depending on basis; top-10 institutional holders not publicly disclosed in sources reviewed (see the AFS "Analysis of shareholders") | — |
T Madzinga | 110,911 shares (about 0.1%) at 31 Dec 2025 | Zonebourse (secondary) |
Competitive Landscape
Market Share by Competitor
| Competitor | Ownership | Segments where it competes with Santam | Indicative scale / share | Source |
|---|---|---|---|---|
Hollard Insurance | Private (Hollard group) | Personal, commercial, partnerships/affinity | 10.5–10.7% share (2024); 2024 written premium R16,155m | KPMG survey (via Moonstone); Axco |
Old Mutual Insure | Old Mutual Ltd | Intermediated personal and commercial; specialist (Mutual & Federal heritage) | 8.73% share; R13,473m (2024) | KPMG; Axco |
Guardrisk | Momentum Group | Cell captives / ART (competes with Centriq and SSI) | 8.44% share (2024) | KPMG survey |
OUTsurance | OUTsurance Group (JSE) | Direct personal and business; tied brokers | 7.89% share (2024). FY to Jun 2026: group P&C GWP +15.7%; normalised earnings R5.6bn; OUTsurance SA normalised earnings +43.3% to R4.2bn | KPMG; Moonstone; Business Day (Sep 2026) |
Discovery Insure | Discovery Ltd | Personal motor (telematics), direct/broker | 2.5–2.7% share (2022–2023, PA data) | PA (ASSA 2023 presentation) |
Bryte Insurance | Fairfax Financial | Commercial and specialist via brokers | About 3.0% share (2022–2023) | PA (ASSA 2023) |
Momentum Insure | Momentum Group | Personal lines (group share including Guardrisk about 9.2–9.3%) | Group 9.2–9.3% (2022–2023) | PA (ASSA 2023) |
Auto & General / Budget / Dial Direct / 1st for Women | Telesure (Hollard-related / private) | Direct personal motor and home (vs MiWay) | — | — |
King Price | Private | Direct and broker personal lines | — | — |
Munich Re of Africa / Hannover Re SA | Global reinsurers | Treaty reinsurance (vs Santam Re); also Santam's reinsurance counterparties | Munich Re Africa 4.8–6.6% share of GWP (2022–2023) | PA (ASSA 2023) |
Lloyd's syndicates / international specialty carriers | Various | Corporate property and casualty (aggressive capacity cited by Santam); London market (vs Syndicate 1918) | Not quantified | AFS FY2024, FY2025 |
“—” = not publicly disclosed.
Peer Comparison FY2025
| Metric | Santam (FY Dec 2025) | OUTsurance Group (FY Jun 2026) | Old Mutual Insure (FY2025) | Hollard (FY2025) |
|---|---|---|---|---|
Premium base | Conventional GWP R43.96bn; IFRS insurance revenue R56.1bn | P&C GWP growth +15.7%; Youi insurance revenue R25.24bn | — | — |
Growth | GWP +6.4%, NEP +14.7% | GWP +15.7%, NEP +18.7% | — | — |
Earnings | Net income R4,059m (+10%) | Normalised earnings R5,605m (+18.5%) | — | — |
Underwriting / combined ratio | Combined ratio 88.7%; UWM 11.3% | — | — | — |
R&D intensity | Not applicable / not disclosed | Not applicable / not disclosed | Not applicable | Not applicable |
SA non-life market share (2024) | 22.99% | 7.89% | 8.73% | 10.47–10.68% |



